Pillstats
Rx only · Tablet, Coated · Oral

Venlafaxine

Venlafaxine Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AX16
RxCUI (US)39786
US makers2 labelers
Packages18
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.126$0.252$0.378$0.505Dec 2025Feb 2026Jul 2026
$0.330
Latest avg · Jul 22, 2026
-21%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.0K4.0K6.0K8.0K2025 Q32025 Q42026 Q1
6.9K
Rx · 2026 Q1
273K
Units dispensed
3
Quarters · since 2025 Q3

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Cadila Pharmaceuticals Limitedunknown9SUPPLYING
Modavar Pharmaceuticals LLCunknown9SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.